Corporate News 15-May-14
Jagsonpal Pharmaceuticals to hold board meeting
on 30 May 2014
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2014 to consider and approve the Audited financial results for the quarter/year ended 31 March 2014, and Recommend dividend, if any, for the year ended 31 March 2014.
Previous News
Jagsonpal Pharmaceuticals standalone net profit rises 707.83% in the December 2024 quarter
( Results - Announcements 23-Jan-25 07:31 )
Jagsonpal Pharmaceuticals standalone net profit rises 138.16% in the December 2020 quarter
( Results - Announcements 12-Feb-21 16:48 )
Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter
( Results - Announcements 07-May-25 07:45 )
Board of Jagsonpal Pharmaceuticals recommends final dividend
( Corporate News - 07-May-25 09:28 )
Board of Jagsonpal Pharmaceuticals recommends final dividend
( Corporate News - 30-Jul-20 11:00 )
Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma
( Corporate News - 31-May-24 14:15 )
Jagsonpal Pharmaceuticals reports standalone net profit of Rs 1.77 crore in the September 2018 quarter
( Results - Announcements 18-Nov-18 17:17 )
Jagsonpal Pharmaceuticals to announce Quarterly Result
( Corporate News - 25-Jul-20 13:45 )
Jagsonpal Pharmaceuticals to hold board meeting
( Corporate News - 05-Nov-15 09:56 )
Jagsonpal Pharmaceuticals announces board meeting date
( Corporate News - 23-Jun-21 12:31 )
Jagsonpal Pharmaceuticals to conduct AGM
( Corporate News - 25-Aug-22 14:52 )
Other Stories
Board of HCL Technologies recommends Interim Dividend
14-Jul-25 17:52
Objectone Information Systems to conduct board meeting
14-Jul-25 17:50
JTEKT India AGM scheduled
14-Jul-25 17:50
Setco Automotive to discuss results
14-Jul-25 17:50
Saurashtra Cement to hold board meeting
14-Jul-25 17:49
John Cockerill India to table results
14-Jul-25 17:49
ATV Projects India to conduct board meeting
14-Jul-25 17:49
Shilchar Technologies schedules AGM
14-Jul-25 17:49
Sun Pharma settles litigation related to LEQSELVI™ with Incyte
14-Jul-25 16:53
Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
14-Jul-25 16:48
Back
Top